Loading...
XNYSDVA
Market cap12bUSD
Dec 31, Last price  
149.55USD
1D
-0.16%
1Q
-6.01%
Jan 2017
132.94%
Name

DaVita Inc

Chart & Performance

D1W1MN
XNYS:DVA chart
P/E
17.73
P/S
1.01
EPS
8.43
Div Yield, %
0.00%
Shrs. gr., 5y
-11.57%
Rev. gr., 5y
1.26%
Revenues
12.14b
+4.57%
2,298,595,0002,973,918,0004,880,662,0005,264,151,0005,660,173,0006,108,800,0006,447,391,0006,791,980,0008,186,280,00011,764,050,00012,795,106,00013,781,837,00014,745,105,00010,876,634,00011,404,851,00011,388,479,00011,550,604,00011,618,797,00011,609,894,00012,140,147,000
Net income
692m
-9.98%
222,254,000228,643,000289,691,000381,778,000374,160,000422,684,000405,683,000478,001,000536,017,000633,446,000723,114,000269,732,000879,874,000663,618,000790,078,000810,981,000773,642,000978,450,000768,191,000691,535,000
CFO
2.06b
+31.60%
419,945,000485,554,000519,571,000533,036,000555,931,000666,710,000839,683,0001,180,046,0001,100,848,0001,773,341,0001,459,407,0001,557,200,0001,963,444,0001,907,449,0001,771,640,0002,072,355,0001,979,028,0001,930,876,0001,564,570,0002,059,031,000
Earnings
Feb 11, 2025

Profile

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
URL
https://www.davita.com/
IPO date
Oct 31, 1995
Employees
70,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
12,140,147
4.57%
11,609,894
-0.08%
Cost of revenue
9,793,701
9,564,750
Unusual Expense (Income)
NOPBT
2,346,446
2,045,144
NOPBT Margin
19.33%
17.62%
Operating Taxes
220,116
198,087
Tax Rate
9.38%
9.69%
NOPAT
2,126,330
1,847,057
Net income
691,535
-9.98%
768,191
-21.49%
Dividends
Dividend yield
Proceeds from repurchase of equity
(320,331)
(802,228)
BB yield
3.28%
11.21%
Debt
Debt current
517,698
626,805
Long-term debt
13,322,274
14,094,154
Deferred revenue
727,136
Other long-term liabilities
910,210
105,233
Net debt
12,854,561
14,123,743
Cash flow
Cash from operating activities
2,059,031
1,564,570
CAPEX
(567,985)
(603,429)
Cash from investing activities
(771,800)
(630,347)
Cash from financing activities
(1,170,495)
(1,118,823)
FCF
2,598,023
2,341,876
Balance
Cash
391,673
321,779
Long term investments
593,738
275,437
Excess cash
378,404
16,721
Stockholders' equity
2,233,546
1,617,865
Invested Capital
13,635,934
14,117,763
ROIC
15.32%
13.04%
ROCE
15.92%
13.71%
EV
Common stock shares outstanding
93,182
95,834
Price
104.76
40.30%
74.67
-34.36%
Market cap
9,761,746
36.41%
7,155,925
-42.79%
EV
24,303,560
22,792,142
EBITDA
3,091,889
2,777,746
EV/EBITDA
7.86
8.21
Interest
398,551
357,019
Interest/NOPBT
16.99%
17.46%